Literature DB >> 32058913

Precursor lesions of vulvar squamous cell carcinoma - histology and biomarkers: A systematic review.

Shatavisha Dasgupta1, Patricia C Ewing-Graham2, Sigrid M A Swagemakers3, Peter J van der Spek4, Helena C van Doorn5, Vincent Noordhoek Hegt6, Senada Koljenović7, Folkert J van Kemenade8.   

Abstract

The precursor lesion of vulvar squamous cell carcinoma (VSCC), namely vulvar intraepithelial neoplasia (VIN), is classified as: human papillomavirus (HPV)-related high grade squamous intraepithelial lesion (HSIL), and HPV-independent differentiated VIN (dVIN). Traditionally, histology and immunohistochemistry (IHC) have been the basis of diagnosis and classification of VIN. HSIL shows conspicuous histological atypia, and positivity on p16-IHC, whereas dVIN shows less obvious histological atypia, and overexpression or null-pattern on p53-IHC. For both types of VIN, other diagnostic immunohistochemical markers have also been evaluated. Molecular characterization of VIN has been attempted in few recent studies, and novel genotypic subtypes of HPV-independent VSCC and VIN have been identified. This systematic review appraises the VSCC precursors identified so far, focusing on histology and biomarkers (immunohistochemical and molecular). To gain further insights into the carcinogenesis and to identify additional potential biomarkers, gene expression omnibus (GEO) datasets on VSCC were analyzed; the results are presented.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Expression array; Histology; Immunohistochemistry; Precursor lesion; Squamous cell carcinoma; Systematic review; Vulva; Vulvar intraepithelial neoplasia

Year:  2020        PMID: 32058913     DOI: 10.1016/j.critrevonc.2020.102866

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  13 in total

1.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

2.  High-risk human papillomavirus-associated vulvar neoplasia among women living with human immunodeficiency virus in Zambia.

Authors:  Fred Maate; Peter Julius; Stepfanie Siyumbwa; Leeya Pinder; Trevor Kaile; Mulindi Mwanahamuntu; Groesbeck Parham
Journal:  Afr J Lab Med       Date:  2022-05-12

3.  Human Papillomavirus‒Positive and ‒Negative Vulvar Squamous Cell Carcinoma Are Biologically but Not Clinically Distinct.

Authors:  Elysha Kolitz; Elena Lucas; Gregory A Hosler; Jiwoong Kim; Suntrea Hammer; Cheryl Lewis; Lin Xu; Andrew T Day; Melissa Mauskar; Jayanthi S Lea; Richard C Wang
Journal:  J Invest Dermatol       Date:  2021-10-28       Impact factor: 7.590

4.  MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin.

Authors:  M T Fernández-Figueras; C Carrato; X Saenz-Sardà; E Musulén; M J Fuente; L Puig
Journal:  Arch Dermatol Res       Date:  2021-10-13       Impact factor: 3.033

5.  Nuclear factor IB is downregulated in vulvar squamous cell carcinoma (VSCC): Unravelling differentially expressed genes in VSCC through gene expression dataset analysis.

Authors:  Shatavisha Dasgupta; Patricia C Ewing-Graham; Thierry P P Van Den Bosch; Sigrid M A Swagemakers; Lindy A M Santegoets; Helena C Van Doorn; Peter J Van Der Spek; Senada Koljenović; Folkert J Van Kemenade
Journal:  Oncol Lett       Date:  2021-03-16       Impact factor: 2.967

6.  Integrin αvβ6 as a Target for Tumor-Specific Imaging of Vulvar Squamous Cell Carcinoma and Adjacent Premalignant Lesions.

Authors:  Bertine W Huisman; Merve Cankat; Tjalling Bosse; Alexander L Vahrmeijer; Robert Rissmann; Jacobus Burggraaf; Cornelis F M Sier; Mariette I E van Poelgeest
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

7.  Prevalence and type distribution of human papillomavirus infections in Danish patients diagnosed with vulvar squamous cell tumors and precursors.

Authors:  Annemarie Brusen Villadsen; Caspar Bundgaard-Nielsen; Lea Ambühl; Majbritt Tang Svendsen; Inge Søkilde Pedersen; Estrid Stæhr Hansen; Ulrik Baandrup; Jan Blaakær; Suzette Sørensen
Journal:  Gynecol Oncol Rep       Date:  2021-07-05

8.  Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.

Authors:  Baojie Wu; Shuyi Xi
Journal:  BMC Cancer       Date:  2021-06-26       Impact factor: 4.430

Review 9.  Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology.

Authors:  Pavol Zubor; Yun Wang; Alena Liskova; Marek Samec; Lenka Koklesova; Zuzana Dankova; Anne Dørum; Karol Kajo; Dana Dvorska; Vincent Lucansky; Bibiana Malicherova; Ivana Kasubova; Jan Bujnak; Milos Mlyncek; Carlos Alberto Dussan; Peter Kubatka; Dietrich Büsselberg; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

10.  Diagnostic Criteria for Differentiated Vulvar Intraepithelial Neoplasia and Vulvar Aberrant Maturation.

Authors:  Debra S Heller; Tania Day; Jill I Allbritton; James Scurry; Gianluigi Radici; Kathryn Welch; Mario Preti
Journal:  J Low Genit Tract Dis       Date:  2021-01-01       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.